» Authors » Sushobhan Mukhopadhyay

Sushobhan Mukhopadhyay

Explore the profile of Sushobhan Mukhopadhyay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 45
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smith K, Panlilio L, Sharma A, McCurdy C, Feldman J, Mukhopadhyay S, et al.
Drug Alcohol Depend . 2024 Oct; 264:112460. PMID: 39405600
Background And Aims: Using ecological momentary assessment (EMA), we undertook a natural experiment wherein kratom-product variability was a tool to assess kratom dose-response relationships based on product form and alkaloid...
2.
Chiang Y, Berthold E, Kuntz M, Kanumuri S, Senetra A, Mukhopadhyay S, et al.
ACS Pharmacol Transl Sci . 2024 Aug; 7(8):2452-2464. PMID: 39144552
This study reports the steady-state pharmacokinetic parameters for mitragynine and characterizes its elimination in male and female rats. Four male and female rats were dosed q12h with 40 mg/kg, and...
3.
Liang Z, Guo Y, Ellin N, King T, Berthold E, Mukhopadhyay S, et al.
Talanta . 2024 Apr; 274:125923. PMID: 38569366
Mitragyna speciosa, more commonly known as kratom, has emerged as an alternative to treat chronic pain and addiction. However, the alkaloid components of kratom, which are the major contributors to...
4.
Berthold E, Kamble S, Kanumuri S, Kuntz M, Senetra A, Chiang Y, et al.
Pharmaceutics . 2024 Mar; 16(3). PMID: 38543213
Kratom and cannabidiol products are used to self-treat a variety of conditions, including anxiety and pain, and to elevate mood. Research into the individual pharmacokinetic properties of commercially available kratom...
5.
Zamarripa C, Spindle T, Panlilio L, Strickland J, Feldman J, Novak M, et al.
Traffic Inj Prev . 2024 Mar; 25(4):594-603. PMID: 38497810
Objectives: Despite widespread kratom use, there is a lack of knowledge regarding its effects on driving. We evaluated the self-reported driving behaviors of kratom consumers and assessed their simulated-driving performance...
6.
Smith K, Rogers J, Sharma A, McCurdy C, Weiss S, Dunn K, et al.
J Addict Med . 2024 Jan; 18(2):144-152. PMID: 38174871
Introduction: Use of kratom has outpaced systematic study of its effects, with most studies reliant on retrospective self-report. Methods: We aimed to assess acute effects following kratom use in adults...
7.
Melchert P, Zhang Q, Mukhopadhyay S, Kanumuri S, McCurdy C, Markowitz J
Chem Biol Interact . 2023 Sep; 384:110715. PMID: 37716419
Kratom, (Mitragyna Speciosa Korth.) is a plant indigenous to Southeast Asia whose leaves are cultivated for a variety of medicinal purposes and mostly consumed as powders or tea in the...
8.
Ortiz Y, Bilbrey J, Felix J, Kienegger E, Mottinelli M, Mukhopadhyay S, et al.
Pharmacol Rep . 2023 May; 75(4):937-950. PMID: 37243887
Background: For many chemotherapy patients peripheral neuropathy is a debilitating side effect. Mitragyna speciosa (kratom) contains the alkaloid mitragynine (MG), which produces analgesia in multiple preclinical pain models. In humans,...
9.
Laforest L, Kuntz M, Kanumuri S, Mukhopadhyay S, Sharma A, OConnor S, et al.
J Nat Prod . 2023 Mar; 86(4):1042-1052. PMID: 36913648
The monoterpene indole alkaloid (MIA) mitragynine has garnered attention as a potential treatment for pain, opioid use disorder, and opioid withdrawal because of its combined pharmacology at opioid and adrenergic...
10.
Mukhopadhyay S, Barak D, Karthik R, Verma S, Bhatta R, Goyal N, et al.
RSC Med Chem . 2021 Jan; 11(9):1053-1062. PMID: 33479698
A chemical library comprising substituted 3-nitroisoxazoles and 3-aminoisoxazoles was prepared and screened for their antileishmanial activity against . As compared to Miltefosine, the standard drug used in bioassays, several compounds...